Please use this identifier to cite or link to this item: http://hdl.handle.net/11189/7230
DC FieldValueLanguage
dc.contributor.authorPhillips, Kevin. C.en_US
dc.contributor.authorClarke-Farr, Peter Cen_US
dc.contributor.authorMatsha, Tandi Edithen_US
dc.contributor.authorMeyer, David.en_US
dc.date.accessioned2020-03-10T06:43:33Z-
dc.date.available2020-03-10T06:43:33Z-
dc.date.issued2018-
dc.identifier.citationPhillips, K. C., Clarke-Farr, P. C., Matsha, T. E. et al. 2018. Biomarkers as a predictor for diabetic retinopathy risk and management: a review. African Vision and Eye Health, 77(1): 430. [https://doi.org/ 10.4102/aveh.v77i1.430]en_US
dc.identifier.issn2410-1516-
dc.identifier.urihttp://hdl.handle.net/11189/7230-
dc.description.abstractBackground: The systemic and ocular manifestations of diabetes are an increasing burden on both private and public healthcare systems. The ability to accurately predict patient susceptibility and prognostic implications of the disease is essential to its optimal management and planning. Aim: The purpose of this paper was to review alternative biomarkers to those currently in use regarding the diagnosis and prognosis of diabetes and the ocular effects of the disease. Current biomarkers include Fasting Plasma Glucose (FPG), Oral Glucose Tolerance Test (OGTT) and Glycolated Haemoglobin (HbA1c). Methods: The research strategy comprised of a comprehensive literature review of articles from Mendeley, Cochrane and Elsevier with additional input from experts in the field serving as co-authors. Results: The review found that there are alternative biomarkers to those currently utilised. These include adiponectin, apolipoprotein B, C-reactive protein and ferritin. Fructosamine, while useful where whole blood is available, is unreliable as a diagnostic biomarker resulting in a 10% variation coefficient. Post-prandial glucose (PPG) measurement most closely predicted HbA1c. Conclusion: With prediction of risk for diabetes in individuals, a value combination, expressed as either a numerical score or a percentage, consisting of adiponectin, apolipoprotein B, C-reactive protein and ferritin, almost doubled the relative risk of contracting the disease. Eye care practitioners need to question diabetic patients about their FPG and HbA1c levels and encourage them to have the relevant tests regularly, including PPG. The importance of biomarkers should be emphasised and used as an educational tool to facilitate better diabetes management and treatment adherence.en_US
dc.language.isoenen_US
dc.publisherOASISen_US
dc.relation.ispartofAfrican Vision and Eye Healthen_US
dc.subjectDiabetesen_US
dc.subjectDiabetic retinopathyen_US
dc.subjectHbA1en_US
dc.subjectAdiponectinen_US
dc.subjectApolipoproteinen_US
dc.subjectRetinopathy Screeningen_US
dc.titleBiomarkers as a predictor for diabetic retinopathy risk and management: a reviewen_US
dc.identifier.doihttps://doi.org/ 10.4102/aveh.v77i1.430-
dc.typeArticleen_US
Appears in Collections:HWSci - Journal Articles (DHET subsidised)
Files in This Item:
File Description SizeFormat 
Biomarkers as a predictor.pdf1.75 MBAdobe PDFView/Open
Show simple item record

Page view(s)

130
checked on Feb 9, 2021

Download(s)

8
checked on Feb 9, 2021

Google ScholarTM

Check

Altmetric


Items in Digital Knowledge are protected by copyright, with all rights reserved, unless otherwise indicated.